Aerpio Pharmaceuticals, Inc. logo
Aerpio Pharmaceuticals, Inc. ARPO

Aerpio Pharmaceuticals, Inc. Net Income 2011-2026 | ARPO

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Aerpio Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.32 M -23.3 M -10.4 M -21.4 M -39.4 K -31.4 K -28.7 K -27.4 K -27.2 K -22.4 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-22.4 K -23.3 M -5.96 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-514 M - 2.43 % $ 254 M germanyGermany
Amarin Corporation plc Amarin Corporation plc
AMRN
-59.1 M $ 14.81 -0.34 % $ 6.04 B irlandaIrlanda
Acer Therapeutics Acer Therapeutics
ACER
-26.2 M - 2.71 % $ 14 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-9.57 M - 4.01 % $ 150 M canadaCanada
I-Mab I-Mab
IMAB
-1.47 B - - $ 866 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-131 M - - $ 86.2 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
-46.4 M $ 3.93 0.26 % $ 335 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-18.4 M - - $ 26.5 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
603 M - - $ 40.3 B usaUSA
Adagene Adagene
ADAG
-33.4 M $ 3.24 13.85 % $ 182 M chinaChina
Biophytis SA Biophytis SA
BPTS
-31.2 M - -13.47 % $ 169 M franceFrance
Akouos Akouos
AKUS
-86.7 M - 0.23 % $ 488 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-4.27 M $ 0.79 -7.27 % $ 4.31 M chinaChina
AlloVir AlloVir
ALVR
-58.8 M - 4.14 % $ 49.1 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-8.09 M - -1.52 % $ 24.7 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-8.63 M - -11.43 % $ 502 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
-12.8 M $ 3.48 -0.98 % $ 8.37 B australiaAustralia
Applied Molecular Transport Applied Molecular Transport
AMTI
-126 M - - $ 10.1 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
Biogen Biogen
BIIB
1.29 B $ 195.63 0.06 % $ 28.7 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-253 M - -24.86 % $ 820 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-25.4 M - -45.71 % $ 1.2 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
-252 M - - $ 3.67 B usaUSA
Athira Pharma Athira Pharma
ATHA
-96.9 M - - $ 269 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-208 M - - $ 1.01 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
-34 M - -0.23 % $ 916 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
72.9 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-48.7 M - 3.16 % $ 1.9 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-384 M $ 216.28 -0.83 % $ 5 B danmarkDanmark
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
7.05 B $ 60.51 1.12 % $ 123 B usaUSA
Aptinyx Aptinyx
APTX
-64.8 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
-76.3 M - -13.39 % $ 1.45 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
-616 M - -6.81 % $ 3.04 B usaUSA
BioNTech SE BioNTech SE
BNTX
10.3 B $ 106.24 0.45 % $ 27.2 B germanyGermany
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
-30.4 M - 17.91 % $ 11.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.37 M - 5.93 % $ 314 M canadaCanada
Brickell Biotech Brickell Biotech
BBI
-5.69 M - -5.38 % $ 6.06 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-14.8 M - -10.17 % $ 12.2 K usaUSA
Athersys Athersys
ATHX
-87 M - 3.77 % $ 22.4 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-11.7 M - -52.27 % $ 4.45 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
-645 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-221 M $ 1.41 1.81 % $ 360 M britainBritain
Burford Capital Limited Burford Capital Limited
BUR
172 M $ 9.33 0.32 % $ 1.51 B britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
-73.9 M $ 14.8 1.13 % $ 4.57 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-14.7 M - 1.93 % $ 17.4 M usaUSA
AVROBIO AVROBIO
AVRO
12.2 M - 1083.1 % $ 745 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-412 M - - $ 867 M germanyGermany
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-57.8 M - - $ 2.17 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-38 M - - $ 7.46 M israelIsrael